Cargando…

Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy

Targeted therapeutics made significant advances in the treatment of patients with advanced clear cell renal cell carcinoma (ccRCC). Resistance and serious adverse events associated with standard therapy of patients with advanced ccRCC highlight the need to identify alternative ‘druggable’ targets to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rustum, Youcef M., Reis, Ryan, Rustum, Tara M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864911/ https://www.ncbi.nlm.nih.gov/pubmed/36674417 http://dx.doi.org/10.3390/ijms24020902

Ejemplares similares

Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma—Bench-to-Bedside Therapy
por: Rustum, Youcef M., et al.
Publicado: (2018)

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment
por: Garje, Rohan, et al.
Publicado: (2018)

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets
por: Swearson, Samuel, et al.
Publicado: (2022)

Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition
por: Chintala, Sreenivasulu, et al.
Publicado: (2012)

Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development
por: Zakharia, Yousef, et al.
Publicado: (2018)

Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing
por: van den Heuvel, Corina N. A. M., et al.
Publicado: (2019)

The Centenary of Bowman’s Exposition of the Renal Unit
por: Maluf, N. S. Rustum
Publicado: (1942)

Are There Head Volume Alterations at 11 to 14 Weeks in Fetuses with Congenital Heart Defects? A First Trimester Case Series
por: Abu-Rustum, Reem S., et al.
Publicado: (2016)

Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers
por: Saifo, Maher S, et al.
Publicado: (2010)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity
por: Ling, Xiang, et al.
Publicado: (2012)

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy
por: Xiang, Zhenfei, et al.
Publicado: (2021)

Alterations of the WNT7A Gene in Clear Cell Renal Cell Carcinomas
por: Kondratov, Aleksandr G., et al.
Publicado: (2012)

Alteration of ASIC1 expression in clear cell renal cell carcinoma
por: Li, Yan, et al.
Publicado: (2015)

Potential Role of Selenium in the Treatment of Cancer and Viral Infections
por: Rataan, Aseel O., et al.
Publicado: (2022)

Architectural Heterogeneity in Tumors Caused by Differentiation Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound
por: Rustum, Youcef M., et al.
Publicado: (2010)

Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma
por: Wang, Zengzeng, et al.
Publicado: (2018)

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
por: Zhang, Ning, et al.
Publicado: (2020)

Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature
por: Asanad, Samuel, et al.
Publicado: (2021)

Integrative medicine to tackle the problem of chronic diseases
por: Roy, Rustum
Publicado: (2010)

Combination drug regimens for metastatic clear cell renal cell carcinoma
por: Khetani, Viraj V, et al.
Publicado: (2020)

Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma
por: Lee, Hyung-Ok, et al.
Publicado: (2017)

Identification of Potential Serum Proteomic Biomarkers for Clear Cell Renal Cell Carcinoma
por: Yang, Juan, et al.
Publicado: (2014)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K., et al.
Publicado: (2022)

Serum tissue factor as a biomarker for renal clear cell carcinoma
por: Silva, Daniel D’Oliveira, et al.
Publicado: (2018)

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab
por: Lyu, Chen, et al.
Publicado: (2023)

Treatment strategies for clear cell renal cell carcinoma: Past, present and future
por: Yang, Junwei, et al.
Publicado: (2023)

Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma
por: Carlo, M.I., et al.
Publicado: (2017)

An Immune Atlas of Clear Cell Renal Cell Carcinoma
por: Chevrier, Stéphane, et al.
Publicado: (2017)

Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients
por: Fernandes, Flávia Gonçalves, et al.
Publicado: (2021)

THE UPTAKE OF INORGANIC ELECTROLYTES BY THE CRAYFISH
por: Maluf, N. S. Rustum
Publicado: (1940)

Comprehensive analysis of somatic copy number alterations in clear cell renal cell carcinoma
por: Tsuyukubo, Takashi, et al.
Publicado: (2020)

Acanthosis Nigricans associated with clear-cell renal cell carcinoma
por: Ferraz de Campos, Fernando Peixoto, et al.
Publicado: (2016)

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma
por: Majer, Weronika, et al.
Publicado: (2015)

TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
por: Yan, Youji, et al.
Publicado: (2019)

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma
por: Palomero, Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4hd7sckl7h6ike4qs7qtk4gll4